Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for stellate multiform amelanotic choroidopathy has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for stellate multiform amelanotic choroidopathy.
6 publications have been identified in PubMed for stellate multiform amelanotic choroidopathy. Research spans Case Report / Case Series (67%), Diagnostic / Biomarker (17%), and Review / Meta-Analysis (17%).
Gracia-Rovira E (2026). [PMID: 41461294](https://pubmed.ncbi.nlm.nih.gov/41461294/). *Arch Soc Esp Oftalmol (Engl Ed)*. [Case Report / Case Series]
Jeon J (2026). [PMID: 41981541](https://pubmed.ncbi.nlm.nih.gov/41981541/). *BMC Ophthalmol*. [Diagnostic / Biomarker]
van Gorcom L (2025). [PMID: 40895090](https://pubmed.ncbi.nlm.nih.gov/40895090/). *Am J Ophthalmol Case Rep*. [Case Report / Case Series]
Carrera W (2025). [PMID: 39820360](https://pubmed.ncbi.nlm.nih.gov/39820360/). *Retin Cases Brief Rep*. [Case Report / Case Series]
Ucan Gunduz G (2025). [PMID: 41432686](https://pubmed.ncbi.nlm.nih.gov/41432686/). *Eur J Ophthalmol*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 7:50 AM UTC
European rare disease database
Meng Y (2025). [PMID: 41452306](https://pubmed.ncbi.nlm.nih.gov/41452306/). *Ophthalmol Retina*. [Review / Meta-Analysis]